Join
Live feed
·
INSIDERFilingvia Quantisnow
Madrigal Pharmaceuticals Inc. logo

President and CEO Sibold William John converted options into 50,000 shares and sold $1,380,816 worth of shares (2,400 units at $575.34), increasing direct ownership by 46% to 150,074 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MDGL· Madrigal Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDGL (Madrigal Pharmaceuticals Inc.) and more on Quantisnow.